These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27898656)

  • 1. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.
    Hübner J; Waldmann A; Geller AC; Weinstock MA; Eisemann N; Noftz M; Bertram S; Nolte S; Volkmer B; Greinert R; Breitbart E; Katalinic A
    Br J Cancer; 2017 Jan; 116(2):253-259. PubMed ID: 27898656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
    Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
    Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.
    Hübner J; Waldmann A; Eisemann N; Noftz M; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
    Eur J Cancer Prev; 2018 Nov; 27(6):563-569. PubMed ID: 28692584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
    Eisemann N; Waldmann A; Katalinic A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
    Eisemann N; Waldmann A; Holleczek B; Katalinic A
    J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.
    Gassenmaier M; Stec T; Keim U; Leiter U; Eigentler TK; Metzler G; Garbe C
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):63-70. PubMed ID: 30051517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic skin cancer screening in Northern Germany.
    Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
    J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Stang A; Jöckel KH
    Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of screening on melanoma incidence and biopsy rates.
    Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
    Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 10-Year Follow-Up Study of Subjects Recruited in a Health Campaign for the Early Diagnosis of Cutaneous Melanoma: Suggestions for the Screening Timetable.
    Cristofolini M; Boi S; Cattoni D; Sicher MC; Decarli A; Micciolo R
    Dermatology; 2015; 231(4):345-52. PubMed ID: 26278413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma mortality following skin cancer screening in Germany.
    Boniol M; Autier P; Gandini S
    BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
    Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
    Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System.
    Matsumoto M; Wack S; Weinstock MA; Geller A; Wang H; Solano FX; Kirkwood JM; Ferris LK
    JAMA Dermatol; 2022 May; 158(5):504-512. PubMed ID: 35385051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
    Katalinic A; Kunze U; Schäfer T
    Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.
    Moloney FJ; Guitera P; Coates E; Haass NK; Ho K; Khoury R; O'Connell RL; Raudonikis L; Schmid H; Mann GJ; Menzies SW
    JAMA Dermatol; 2014 Aug; 150(8):819-27. PubMed ID: 24964862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study.
    Carli P; Nardini P; Crocetti E; De Giorgi V; Giannotti B
    Melanoma Res; 2004 Oct; 14(5):403-7. PubMed ID: 15457097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
    Katalinic A; Eisemann N; Waldmann A
    Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
    van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
    Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
    Stang A; Jöckel KH; Heidinger O
    Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.